119 related articles for article (PubMed ID: 31828417)
41. CCND1, NOP14 and DNMT3B are involved in miR-502-5p-mediated inhibition of cell migration and proliferation in bladder cancer.
Ying Y; Li J; Xie H; Yan H; Jin K; He L; Ma X; Wu J; Xu X; Fang J; Wang X; Zheng X; Liu B; Xie L
Cell Prolif; 2020 Feb; 53(2):e12751. PubMed ID: 31971654
[TBL] [Abstract][Full Text] [Related]
42. miR 1296-5p Inhibits the Migration and Invasion of Gastric Cancer Cells by Repressing ERBB2 Expression.
Shan X; Wen W; Zhu D; Yan T; Cheng W; Huang Z; Zhang L; Zhang H; Wang T; Zhu W; Zhu Y; Zhu J
PLoS One; 2017; 12(1):e0170298. PubMed ID: 28099468
[TBL] [Abstract][Full Text] [Related]
43. MiR-490-5p Inhibits Hepatocellular Carcinoma Cell Proliferation, Migration and Invasion by Directly Regulating ROBO1.
Chen W; Ye L; Wen D; Chen F
Pathol Oncol Res; 2019 Jan; 25(1):1-9. PubMed ID: 28924964
[TBL] [Abstract][Full Text] [Related]
44. Identification and Functional Evaluation of miR-4633-5p as a Biomarker and Tumor Suppressor in Metastatic Melanoma.
Zou B; Zhu W; Liu H; Wang S; Zhu H
Cell Physiol Biochem; 2018; 49(4):1364-1379. PubMed ID: 30205394
[TBL] [Abstract][Full Text] [Related]
45. miR-582-5p is a potential prognostic marker in human non-small cell lung cancer and functions as a tumor suppressor by targeting MAP3K2.
Wang LL; Zhang M
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7760-7767. PubMed ID: 30536321
[TBL] [Abstract][Full Text] [Related]
46. miR-199a-5p confers tumor-suppressive role in triple-negative breast cancer.
Chen J; Shin VY; Siu MT; Ho JC; Cheuk I; Kwong A
BMC Cancer; 2016 Nov; 16(1):887. PubMed ID: 27842518
[TBL] [Abstract][Full Text] [Related]
47. MiRNA-615-5p functions as a tumor suppressor in pancreatic ductal adenocarcinoma by targeting AKT2.
Sun Y; Zhang T; Wang C; Jin X; Jia C; Yu S; Chen J
PLoS One; 2015; 10(4):e0119783. PubMed ID: 25856297
[TBL] [Abstract][Full Text] [Related]
48. Upregulation of microRNA-524-5p enhances the cisplatin sensitivity of gastric cancer cells by modulating proliferation and metastasis via targeting SOX9.
Wang J; Xue X; Hong H; Qin M; Zhou J; Sun Q; Liang H; Gao L
Oncotarget; 2017 Jan; 8(1):574-582. PubMed ID: 27880941
[TBL] [Abstract][Full Text] [Related]
49. Overexpression of miR-584-5p inhibits proliferation and induces apoptosis by targeting WW domain-containing E3 ubiquitin protein ligase 1 in gastric cancer.
Li Q; Li Z; Wei S; Wang W; Chen Z; Zhang L; Chen L; Li B; Sun G; Xu J; Li Q; Wang L; Xu Z; Xia Y; Zhang D; Xu H; Xu Z
J Exp Clin Cancer Res; 2017 Apr; 36(1):59. PubMed ID: 28431583
[TBL] [Abstract][Full Text] [Related]
50. MicroRNA-22 targets FMNL2 to inhibit melanoma progression via the regulation of the Wnt/β-catenin signaling pathway and epithelial-mesenchymal transition.
Shi L; Huo JW; Chen SS; Xue JX; Gao WY; Li XY; Song YH; Xu HT; Zhu XW; Chen K
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5332-5342. PubMed ID: 31298385
[TBL] [Abstract][Full Text] [Related]
51. MiR-374b-5p suppresses RECK expression and promotes gastric cancer cell invasion and metastasis.
Xie J; Tan ZH; Tang X; Mo MS; Liu YP; Gan RL; Li Y; Zhang L; Li GQ
World J Gastroenterol; 2014 Dec; 20(46):17439-47. PubMed ID: 25516656
[TBL] [Abstract][Full Text] [Related]
52. miR-138-5p induces aggressive traits by targeting Trp53 expression in murine melanoma cells, and correlates with poor prognosis of melanoma patients.
da Cruz AT; Hunger A; de Melo FHM; Monteiro AC; Paré GC; Lai D; Alves-Fernandes DK; Ayub ALP; Cordero EM; Filho JFDS; Schneider-Stock R; Strauss BE; Tron V; Jasiulionis MG
Neoplasia; 2021 Aug; 23(8):823-834. PubMed ID: 34246986
[TBL] [Abstract][Full Text] [Related]
53. MicroRNA-365 inhibits growth, invasion and metastasis of malignant melanoma by targeting NRP1 expression.
Bai J; Zhang Z; Li X; Liu H
Int J Clin Exp Pathol; 2015; 8(5):4913-22. PubMed ID: 26191184
[TBL] [Abstract][Full Text] [Related]
54. MiR-122-5p inhibits cell migration and invasion in gastric cancer by down-regulating DUSP4.
Xu X; Gao F; Wang J; Tao L; Ye J; Ding L; Ji W; Chen X
Cancer Biol Ther; 2018 May; 19(5):427-435. PubMed ID: 29509059
[TBL] [Abstract][Full Text] [Related]
55. Chondroitin polymerizing factor (CHPF) promotes development of malignant melanoma through regulation of CDK1.
Sun W; Zhao F; Xu Y; Huang K; Guo X; Zheng B; Liu X; Luo Z; Kong Y; Xu M; Schadendorf D; Chen Y
Cell Death Dis; 2020 Jul; 11(7):496. PubMed ID: 32612115
[TBL] [Abstract][Full Text] [Related]
56. miR-186-5p targeting SIX1 inhibits cisplatin resistance in non-small-cell lung cancer cells (NSCLCs).
Liu X; Zhou X; Chen Y; Huang Y; He J; Luo H
Neoplasma; 2020 Jan; 67(1):147-157. PubMed ID: 31686523
[TBL] [Abstract][Full Text] [Related]
57. MiR-296-5p suppresses papillary thyroid carcinoma cell growth via targeting PLK1.
Zhou SL; Tang QL; Zhou SX; Ren RZ
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2084-2091. PubMed ID: 30915753
[TBL] [Abstract][Full Text] [Related]
58. Dysregulation of microRNA-106a-5p-RUNX1 axis associates with clinical progression and prognosis of osteosarcoma patients.
Chen K; Pan G
Pathol Res Pract; 2019 Dec; 215(12):152686. PubMed ID: 31711673
[TBL] [Abstract][Full Text] [Related]
59. miR-17-5p suppresses cell proliferation and invasion by targeting ETV1 in triple-negative breast cancer.
Li J; Lai Y; Ma J; Liu Y; Bi J; Zhang L; Chen L; Yao C; Lv W; Chang G; Wang S; Ouyang M; Wang W
BMC Cancer; 2017 Nov; 17(1):745. PubMed ID: 29126392
[TBL] [Abstract][Full Text] [Related]
60. miR-106a-5p Suppresses the Proliferation, Migration, and Invasion of Osteosarcoma Cells by Targeting HMGA2.
He QY; Wang GC; Zhang H; Tong DK; Ding C; Liu K; Ji F; Zhu X; Yang S
DNA Cell Biol; 2016 Sep; 35(9):506-20. PubMed ID: 27383537
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
